Literature DB >> 9228084

Differential regulation of adenylyl cyclases by Galphas.

A Harry1, Y Chen, R Magnusson, R Iyengar, G Weng.   

Abstract

Regulation of adenylyl cyclases 1, 2, and 6 by Galphas was studied. All three mammalian adenylyl cyclases were expressed in insect (Sf9 or Hi-5) cells by baculovirus infection. Membranes containing the different adenylyl cyclases were stimulated by varying concentrations of mutant (Q227L) activated Galphas expressed in reticulocyte lysates. Galphas stimulation of AC1 involved a single site and had an apparent Kact of 0.9 nM. Galphas stimulation of AC2 was best explained by a non-interactive two site model with a "high affinity" site at 0.9 nM and a "low affinity" site at 15 nM. Occupancy of the high affinity site appears to be sufficient for Gbetagamma stimulation of AC2. Galphas stimulation of AC6 was also best explained by a two-site model with a high affinity site at 0. 6-0.8 nM and a low affinity site at 8-22 nM; however, in contrast to AC2, only a model that assumed interactions between the two sites best fit the AC6 data. With 100 microM forskolin, Galphas stimulation of all three adenylyl cyclases showed very similar profiles. Galphas stimulation in the presence of forskolin involved a single site with apparent Kact of 0.1-0.4 nM. These observations indicate a conserved mechanism by which forskolin regulates Galphas coupling to the different adenylyl cyclases. However, there are fundamental differences in the mechanism of Galphas stimulation of the different adenylyl cyclases with AC2 and AC6 having multiple interconvertible sites. These mechanistic differences may provide an explanation for the varied responses by different cells and tissues to hormones that elevate cAMP levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228084     DOI: 10.1074/jbc.272.30.19017

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Choreographing the adenylyl cyclase signalosome: sorting out the partners and the steps.

Authors:  Rennolds S Ostrom; Amy S Bogard; Robert Gros; Ross D Feldman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-10-20       Impact factor: 3.000

2.  Adenylyl cyclases: expression in the developing rat thalamus and their role in absence epilepsy.

Authors:  Petra Ehling; Tatyana Kanyshkova; Arnd Baumann; Peter Landgraf; Sven G Meuth; Hans-Christian Pape; Thomas Budde
Journal:  J Mol Neurosci       Date:  2012-04-25       Impact factor: 3.444

3.  A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and cAMP Signaling.

Authors:  Monica Soto-Velasquez; Michael P Hayes; Aktan Alpsoy; Emily C Dykhuizen; Val J Watts
Journal:  Mol Pharmacol       Date:  2018-06-27       Impact factor: 4.436

4.  N terminus of type 5 adenylyl cyclase scaffolds Gs heterotrimer.

Authors:  Rachna Sadana; Nathan Dascal; Carmen W Dessauer
Journal:  Mol Pharmacol       Date:  2009-09-25       Impact factor: 4.436

5.  Identification of an intramolecular interaction between small regions in type V adenylyl cyclase that influences stimulation of enzyme activity by Gsalpha.

Authors:  K Scholich; C Wittpoth; A J Barbier; J B Mullenix; T B Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

6.  Gain-of-function screen of α-transducin identifies an essential phenylalanine residue necessary for full effector activation.

Authors:  Shawn K Milano; Chenyue Wang; Jon W Erickson; Richard A Cerione; Sekar Ramachandran
Journal:  J Biol Chem       Date:  2018-09-28       Impact factor: 5.157

7.  The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.

Authors:  Yogesh Kumar Vashist; Asad Kutup; Safije Musici; Emre F Yekebas; Sormeh Mina; Guentac Uzunoglu; Oliver Zehler; Alexandra Koenig; Guelle Cataldegirmen; Maximillian Bockhorn; Katharina Effenberger; Viacheslav Kalinin; Klaus Pantel; Jakob R Izbicki
Journal:  Cell Oncol (Dordr)       Date:  2011-02-22       Impact factor: 6.730

8.  Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch-Nyhan disease: BODIPY-forskolin as pharmacological tool.

Authors:  Liz Kinast; Juliane von der Ohe; Heike Burhenne; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-03       Impact factor: 3.000

9.  GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma.

Authors:  Klaus J Schmitz; Hauke Lang; Ulrich H Frey; Georgios C Sotiropoulos; Jeremias Wohlschlaeger; Henning Reis; Atsushi Takeda; Winfried Siffert; Kurt W Schmid; Hideo A Baba
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

10.  Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Galphas stimulation.

Authors:  Y Chen; A Harry; J Li; M J Smit; X Bai; R Magnusson; J P Pieroni; G Weng; R Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.